Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,963 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis.
Sumida Y, Yoneda M, Tokushige K, Kawanaka M, Fujii H, Yoneda M, Imajo K, Takahashi H, Eguchi Y, Ono M, Nozaki Y, Hyogo H, Koseki M, Yoshida Y, Kawaguchi T, Kamada Y, Okanoue T, Nakajima A, Jsg-Nafld JSGON. Sumida Y, et al. Among authors: fujii h. Int J Mol Sci. 2020 Mar 11;21(6):1907. doi: 10.3390/ijms21061907. Int J Mol Sci. 2020. PMID: 32168769 Free PMC article. Review.
Activation of B-Myb by E2F1 in hepatocellular carcinoma.
Nakajima T, Yasui K, Zen K, Inagaki Y, Fujii H, Minami M, Tanaka S, Taniwaki M, Itoh Y, Arii S, Inazawa J, Okanoue T. Nakajima T, et al. Among authors: fujii h. Hepatol Res. 2008 Sep;38(9):886-95. doi: 10.1111/j.1872-034X.2008.00324.x. Hepatol Res. 2008. PMID: 18624722
A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.
Sumida Y, Yoneda M, Hyogo H, Yamaguchi K, Ono M, Fujii H, Eguchi Y, Suzuki Y, Imai S, Kanemasa K, Fujita K, Chayama K, Yasui K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Sumida Y, et al. Among authors: fujii h. J Gastroenterol. 2011 Feb;46(2):257-68. doi: 10.1007/s00535-010-0305-6. Epub 2010 Sep 15. J Gastroenterol. 2011. PMID: 20842510
Simple formula to predict response to peginterferon alpha2b and ribavirin combination therapy in genotype 1 chronic hepatitis C patients with high viral loads.
Itoh Y, Nishimura T, Hashimoto H, Yamaguchi K, Niimi T, Yokomizo C, Fujii H, Minami M, Yasui K, Mitsuyoshi H, Okanoue T, Takehara T, Hiasa Y, Onji M, Yoshikawa T. Itoh Y, et al. Among authors: fujii h. Hepatol Res. 2011 Feb;41(2):126-32. doi: 10.1111/j.1872-034X.2010.00750.x. Hepatol Res. 2011. PMID: 21269382
Platelet count for predicting fibrosis in nonalcoholic fatty liver disease.
Yoneda M, Fujii H, Sumida Y, Hyogo H, Itoh Y, Ono M, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Imajo K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease. Yoneda M, et al. Among authors: fujii h. J Gastroenterol. 2011 Nov;46(11):1300-6. doi: 10.1007/s00535-011-0436-4. Epub 2011 Jul 13. J Gastroenterol. 2011. PMID: 21750883
3,963 results